Sort
39,280 grants matching “leukemia”
Cancer and Leukemia Group B - Leukemia Correlative Sciences
$783,858Guido Marcucci · Ohio State University · U10 · FY2011 · CA
Beta3 Integrins - Translation of Molecular Structure to Improved Therapeutics
$783,775Barry Coller · Rockefeller University · R01 · FY2020 · HL
Metal mixtures, epigenome, adiposity and cardiometabolic risk across early life
$783,680Gang Hu · Lsu Pennington Biomedical Research Ctr · R01 · FY2025 · DK
A Center of Molecular Developmental Hematopoiesis
$783,356Stuart H Orkin · Boston Children'S Hospital · P30 · FY2006 · DK
The genetic and epigenetic etiology of progression from the precursor state to chronic lymphocytic leukemia (CLL)
$783,300Susan L Slager · Mayo Clinic Rochester · R01 · FY2024 · CA
The Family Bridge Program to Address Communication and Navigation-Related Inequities for Minority Children and Families: A Randomized Controlled Trial
$783,146Katherine Casey Lion · Seattle Children'S Hospital · R01 · FY2023 · MD
Transformative Computational Infrastructures for Cell-Based Biomarker Diagnostics
$782,929Richard H Scheuermann · J. Craig Venter Institute, Inc. · U01 · FY2017 · TR
Lymphoma Studies
$782,468Wyndham H Wilson · Division Of Clinical Sciences - Nci · ZIA · FY2016 · CA
Phase I Clinical Trials of Anti-Cancer Agents
$782,412Mark J Ratain · University Of Chicago · U01 · FY2009 · CA
DEVELOPMENTAL FUNDS (Core 002)
$781,532Michael A Caligiuri · Ohio State University · P30 · FY2016 · CA
Novel Biologic Therapies for BMT: Mechanistic Evaluation in Rhesus Macaques
$781,408Leslie S Kean · Seattle Children'S Hospital · R01 · FY2014 · HL
Studies of Atomic Bomb Survivors
$781,251Kiyohiko Mabuchi · Division Of Cancer Epidemiology And Genetics · ZIA · FY2013 · CA
Phase I Clinical Trials of Anti-Cancer Agents
$780,771Mark J Ratain · University Of Chicago · U01 · FY2011 · CA
Phase I Clinical Trials of Anti-Cancer Agents
$780,770Mark J Ratain · University Of Chicago · U01 · FY2013 · CA
Phase I Clinical Trials of Anti-Cancer Agents
$780,769Mark J Ratain · University Of Chicago · U01 · FY2012 · CA
Multiplex Epitope Editing to Enable Novel Immunotherapies for Acute Myeloid Leukemia
$780,389Pietro Genovese · Boston Children'S Hospital · R01 · FY2024 · CA
Engineering T cells to Promote Islet Transplant
$780,000James L Riley · University Of Pennsylvania · R01 · FY2022 · DK
Targeting the BCL2 immune checkpoint to enhance the immunostimulatory effects of radiation in breast cancer
$779,894Lorenzo Galluzzi · Research Inst Of Fox Chase Can Ctr · R01 · FY2025 · CA
Whole Genome Association Analysis of Hematopoietic Cell Transplant (HCT) Outcome
$779,781John Andrew Hansen · Fred Hutchinson Cancer Research Center · R01 · FY2017 · HL
Clonal hematopoiesis and inherited genetic variation in sickle cell disease
$779,601Alexander Bick · Vanderbilt University Medical Center · R01 · FY2025 · HL
High Resolution Multiplexed DNA reverse-SSO Typing Assay
$779,516Jar-How Lee · One Lambda, Inc. · R44 · FY2007 · AI
Establishing the dynamics of lymphoid clonal hematopoiesis and its aging-related disease consequences
$779,363Alexander Bick · Vanderbilt University Medical Center · R01 · FY2023 · AG
Medical University of South Carolina NCORP Minority/Underserved Community Site
$779,181Chanita A Hughes-Halbert · Medical University Of South Carolina · UG1 · FY2014 · CA
IL-2:IL-15 : implications for cancer therapy
$779,153Thomas Waldmann · Division Of Clinical Sciences - Nci · ZIA · FY2022 · CA
The Family Bridge Program to Improve Communication and Navigation-Related Outcomes for Minority Children and Families: A Randomized Controlled Trial
$779,022Katherine Casey Lion · Seattle Children'S Hospital · R01 · FY2025 · MD